A group of researchers’ claims that people prescribed with “anti-depressants” can make their medication more effective with “certain nutritional supplements”.
Their findings show that S-adenosylmethionine, Vitamin D, Omega 3 from fish oils, and methylfolate, a “bioactive form of folate”, enhance the anti-depressants medicines’ effect, besides acting as a “mood enhancing therapy” for the patients in depression.
The group of researchers were from Harvard and the “University of Melbourne”, who got together to analyse forty “clinical trials” while conducting a “systematic review” or “nutraceuticals” of nutrient supplements to find an effective treatment method of curing “depression in tandem with antidepressants”. Jerome Sarris comes from the Australian “University of Melbourne” and also is the lead author of the study. In Sarris’ words”
"The strongest finding from our review was that Omega 3 fish oil -- in combination with antidepressants -- had a statistically significant effect over a placebo”.
One can pin point numerous studies that highlight the benefits of Omega 3 for maintaining “general brain health” along with the improvement in mood. However, the said study, for the first time, analyses its use “in combination with antidepressant medication”. Moreover, Sarris continued:
"The difference for patients taking both antidepressants and Omega 3, compared to a placebo, was highly significant. This is an exciting finding because here we have a safe, evidence-based approach that could be considered a mainstream treatment”.
However, the group came up with “mixed results for zinc, vitamin C and tryptophan (an amino acid)”. In fact, inositol and folic acid’s performance have been disappointing in particular. According to Sarris:
"Medical practitioners are aware of the benefits of omega 3 fatty acids, but are probably unaware that one can combine them with antidepressant medication for a potentially better outcome”.
"We're not telling people to rush out and buy buckets of supplements. Always speak to your medical professional before changing or initiating a treatment”.
The said study has been published in the “American Journal of Psychiatry”.
References:
http://timesofindia.indiatimes.com/
Their findings show that S-adenosylmethionine, Vitamin D, Omega 3 from fish oils, and methylfolate, a “bioactive form of folate”, enhance the anti-depressants medicines’ effect, besides acting as a “mood enhancing therapy” for the patients in depression.
The group of researchers were from Harvard and the “University of Melbourne”, who got together to analyse forty “clinical trials” while conducting a “systematic review” or “nutraceuticals” of nutrient supplements to find an effective treatment method of curing “depression in tandem with antidepressants”. Jerome Sarris comes from the Australian “University of Melbourne” and also is the lead author of the study. In Sarris’ words”
"The strongest finding from our review was that Omega 3 fish oil -- in combination with antidepressants -- had a statistically significant effect over a placebo”.
One can pin point numerous studies that highlight the benefits of Omega 3 for maintaining “general brain health” along with the improvement in mood. However, the said study, for the first time, analyses its use “in combination with antidepressant medication”. Moreover, Sarris continued:
"The difference for patients taking both antidepressants and Omega 3, compared to a placebo, was highly significant. This is an exciting finding because here we have a safe, evidence-based approach that could be considered a mainstream treatment”.
However, the group came up with “mixed results for zinc, vitamin C and tryptophan (an amino acid)”. In fact, inositol and folic acid’s performance have been disappointing in particular. According to Sarris:
"Medical practitioners are aware of the benefits of omega 3 fatty acids, but are probably unaware that one can combine them with antidepressant medication for a potentially better outcome”.
"We're not telling people to rush out and buy buckets of supplements. Always speak to your medical professional before changing or initiating a treatment”.
The said study has been published in the “American Journal of Psychiatry”.
References:
http://timesofindia.indiatimes.com/
